Research progress in the biological markers of brain metastases from lung cancer

doi:10.3877/cma.j.issn.2095-5820.2016.04.006

Abstract

Abstract:

The incidence and mortality is both high in brain metastases from lung cancer, and therefore the find of simple and accurate indicators is of great significance to the diagnosis and treatment of the brain metastases from lung cancer. With the development of molecular biology, many new biological markers that have good application prospects in the diagnosis and treatment of brain metastases from lung cancer were found and researched in recent years. This article will review the research progress and current situation of the peripheral blood and histological molecular markers in the brain metastases from lung cancer.

Key words: Lung cancer, Brain metastases, Molecular markers

Lihong Zhang, Xuejun Dong, Hongbin Wang, Zhuang Zheng. Research progress in the biological markers of brain metastases from lung cancer[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2016, 04(04): 219-222.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcsysgldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5820.2016.04.006

https://zhlcsysgldzzz.cma-cmc.com.cn/EN/Y2016/V04/I04/219

References 33

1	Chen W, Zheng R, Zeng H, et a1. Annual report on status of cancer in China, 2011[J]. Chin J Cancer Res, 2015, 27:2-12.
2	Preusser M, Capper D, llhan-Mutlu A, et a1. Brain metastases: pathobiology and emerging targeted therapies[J]. Acta Neuropathol, 2012,123(2):205-222．
3	Soffietti R, Cornu P, Delattre JY, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force[J]. Eur J Neurol, 2006,13(7):674-681.
4	Liu W, Zhao J, Wei Y. Association between brain metastasis from lung cancer and the serum level of myelin basic protein[J]. Exp Ther Med, 2015,9:1048-1050.
5	Vogelbaum MA, Masaryk T, Mazzone P, et al. S100 β as a predictor of brain metastases: Brain versus cerebrovascular damage[J]. Cancer, 2005,15:104(4):817-824.
6	Pang X, Min J, Liu L, et al. S100B protein as a possible participant in the brain metastasis of NSCLC[J]. Med Oncol, 2012,29(4):2626-2632.
7	Mir S, Ali F, Chauhan D, et al. Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis[J]. Metab Brain Dis, 2016,31(2):299-309.
8	Nagdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia[J]. Pediatr Res, 2001,49(4):502-506．
9	Núñez C, Lozada-Requena I, Ysmodes T, et al. Immunomodulation of Uncaria tomentosa over dendritic cells, il-12 and profile TH1/TH2/TH17 in breast cancer[J]. Rev Peru Med Exp Salud Publica, 2015,32(4):643-651.
10	Rizzo A, De Mare V, Rocchi C, et al. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells[J]. Carcinogenesis, 2014,35(7):1536-1546.
11	He G1, Zhang B, Zhang B, et al. Th17 cells and IL-17 are increased in patients with brain metastases from the primary lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2013,16(9):476-481.
12	Noris-Garcia E, Eseobar-Perez X. Brain metastasis and the carcinoembryonic antigen[J]. Rev Neurol, 2004,38(3):267-270．
13	Lee DS, Kim YS, Jung SL, et a1. The relevance of serum carcinoembryonic antigen as an indicator of brain metastasis detection in advanced non-small cell lung cancer[J]. Tumour Biol, 2012,33(4):1065-1073.
14	Janowski M. Functional diversity of SDF-1 splicing variants[J]. Cell Adh Migr, 2009,3(3):243-249.
15	Chen G, Wang Z, Liu XY, et al. High-level Cxcr4 expression correlates with brain-specific metastasis of non-small cell lung cancer[J]. World J Surg, 2011,35(1):56-61.
16	Salmaggi A, Maderna E, Calatozzolo C, et al. CXCL2, CXCR4 and CXCR7 expression in brain metastases[J]. Cancer Biol Ther, 2009,8(17):1608-1614.
17	Ma S, Liu X, Geng JG, et al. Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma[J]. Am J Obstet Gynecol, 2010,202(1):68.e1-68.e11.
18	李晓霞，金玲，孙增峰, 等. Robo1蛋白在非小细胞肺癌和肺癌脑转移组织中的表达及意义[J]. 中华肿瘤杂志, 2013,35(3):198-201.
19	解刚强，刘德纯，陈登庭, 等. 转化生长因子-βl诱导的半胱氨酰天冬氨酸特异性蛋白酶依赖的人胃癌细胞凋亡途径[J]. 中华实验外科杂志, 2012,29(8):1553-1555．
20	姜冠潮，廖贻达，李晓, 等. 半胱氨酰天冬氨酸特异性蛋白酶-8对非小细胞肺癌脑转移的预测价值[J]. 中华实验外科杂志, 2014,31(12):2894-2896.
21	Wang HM, Wang J. Expression of Tiam1 in lung cancer and its clinical significance[J]. Asian Pac J Cancer Prev, 2012,13(2):613-615.
22	Li YM, Qi WJ, Shen H. Quantitative analysis of Tiam1 expression in lung cancer and its clinical significance[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2011,31(10):1774-1777.
23	Weng MX, Wu CH, Yang XP. Expression and significance of E-cadherin, CD44V6, and proliferating cell nuclear antigen in non-small cell lung cancer[J]. Chin J Cancer, 2008,27(2): 191-195.
24	Yoo JY, Yang SH, Lee JE, et al. E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model[J]. J Neurooncol, 2012,109(2):219-227.
25	Xu H, Tian Y, Yuan X, et al. Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis[J]. Onco Targets Ther, 2016,9:431-444.
26	Chen QY, Yan J, Hu HZ, et al. Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis[J]. Zhonghua Zhong Liu Za Zhi, 2012,34(6):436-440.
27	Baek MY, Ahn HK, Park KR, et al. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer[J/OL]. Korean J Intern Med, 2015.158.[2016-04-20]. published online ahead of print April 20, 2016] URL
28	皮新苗，李泽宇，马怡然, 等. MIP-1a诱导肺癌脑转移患者CIK细胞跨内皮迁移的研究[J]. 中国医科大学学报, 2016,45(2):141-149.
29	Shintani Y, Higashiyama S, Ohta M, et a1. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis[J]. Cancer Res, 2004,64(12):4190-4196.
30	GaoY, Li G, Sun L, et al. ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain[J]. BMC Cancer, 2015,15:277.
31	Wu C, Asokan SB, Berginski ME, et a1. Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis[J]. Cell, 2012,148(5):973-987.
32	Zhao H, Xie C, Lin X, et al. Coexpression of IQ-domain GTPase-activating protein 1 (IQGAP1) and Dishevelled (Dvl) is correlated with poor prognosis in non-small cell lung cancer[J]. PLoS One, 2014,9(12):e113713.
33	Pishko GL, Muldoon LL, Pagel MA, et al. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis[J]. Fluids Barriers CNS, 2015,12:5.

[1]	Chenglu Huang, Fei Liao, Xianping Liu, Zhiqiang Wang. Relationship between overexpression of serum exosomal has_circ_0060937 and metastasis and poor prognosis of NSCLC [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(04): 490-494.
[2]	Yiran Li, Yuxiu Wang, Yan Zhu, Meng Wang, Ying Liu, Wenjin Yan, Xingxiang Xu, Lingfeng Min. Analysis of differential genes that affect the efficacy of Nivolumab and Pembrolizumab in the treatment of non-small cell lung cancer based on GEO database [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(01): 20-25.
[3]	jianhui Zuo, Yu Chen, Chuntong Yin. Prediction of efficacy and prognosis of Cho/Cr ratio combined with serum NSE in patients with lung cancer brain metastases/bone metastases [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(01): 39-42.
[4]	Rongrong Ma, Zongjuan Ming, Wei Li, Dexin Zhang, Shuanying Yang. Characteristics and mechanism of pathological transformation of lung adenocarcinoma [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(06): 782-786.
[5]	Yuan Wang, Yi Yang, Yunfei Mou, Fuqiang Ren, Xin Huang. Analysis of postoperative osimertinib targeted therapy in patients with resectable non-small cell lung cancer [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(05): 657-660.
[6]	Dong Wei, Yunchao Xin, Bo Liu, Yu Rong, Yanming Li, Yanbing Hao. Predictive value of PROX1 for recurrence after minimally invasive resection of early non-small cell lung cancer [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(04): 494-497.
[7]	Xiaomei He, Xingmin Wang, Junzhi Xiong, Rongrong Chen, Qian Min, Kebin Zhang, Yuanyuan Li. Construction of prognostic model of lung cancer based on transcription factors and its clinical significance [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(04): 462-467.
[8]	Xiaokuang Ning, Puming Hao, Rui Yan, Yunze Liu, Chengrun Li. Analysis of a study about single-direction three-port thoracoscopic surgery lobectomy for early-stage lung cancer [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(04): 227-232.
[9]	Zhipeng Zhao, Yongfu Ma, Changjiang Feng, Meng Zhang, Yang Liu. A single-center retrospective analysis of a surgical strategy based on pulmonary sub-segments [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(02): 85-90.
[10]	Kaimei Gan, Jian Huang. Research progress in the effect of lung cancer stem cells on EGFR-TKI drug resistance [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(01): 36-44.
[11]	Shan Yang, Wei Gao, Meng Cheng, Jiajie Shi, Cuizhi Geng, Sainan Li. Clinicopathological features and prognostic factors of patients with breast cancer combined with primary lung cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(10): 975-981.
[12]	Hongjia Li, Yuenian Xing, Shiyue Li, Changhao Zhong. Status and progress of cryoablation in the treatment of peripheral lung cancer [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2023, 11(02): 172-178.
[13]	Yaqiong Xiong, Wenze Tian, Xuechun Leng, Zhenbing You, Xinqi Wei. Application of cluster intervention in postoperative intractable cough of lung cancer [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2023, 10(04): 207-212.
[14]	Ao Liu, Yandong Zhao, Tong Qiu, Yunpeng Xuan, Xiao Sun, Yi Qin, Rongjian Xu, Wenxing Du, Zhe Wu, Wenjie Jiao. Robot-assisted bronchial sleeve lobectomy—from margin to prognosis [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2022, 09(04): 217-222.
[15]	Ping Li, Weifen Liang, Yijun Zhang, Guizhen Xiao, Linxin Zheng, Haohua Li. Effect of nutritional support in respiratory rehabilitation therapy for elderly patients with advanced lung cancer [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2023, 10(01): 20-25.

Please choose a citation manager

Content to export